MicroRNAs (miRNAs) regulate mammalian gene expression by targeting mRNAs and have key roles in several cellular processes, including differentiation, development, apoptosis and cancer pathomechanisms. Our previous studies have confirmed that a proliferation-inducing ligand (APRIL) gene is overexpressed in colorectal cancer (CRC) tumors and SW480 cells. To study the potential mechanisms of APRIL gene in the occurrence and development of the CRC, herein, we investigated whether APRILknockdown had the inhibitory effect on the growth of SW480 cells and had the simultaneous expression changes of miRNAs and mRNAs by microarrays. Our results suggest that siRNA-APRIL can effectively inhibit the growth of SW480 cells in vitro and in vivo and several miRNAs via specific pathways might be involved in regulating the phenotype of loss-of-function in APRIL-knockdown SW480 cells. Thus, our study highlights the possible mechanisms of miRNA-target regulating the function of APRIL gene in CRC cells, moreover, siRNA-APRIL holds great promise as a novel gene therapy approach for APRIL-positive CRC treatment.
Introduction
MicroRNAs (miRNAs) are short non-coding RNAs of about 22 nt length that have recently been shown to have important roles in mammalian gene expression. By binding the 3 0 untranslated regions of their target genes, miRNAs induce posttranscriptional gene repression through either blocking protein translation or inducing mRNA degradation. 1, 2 However, recent evidences suggest that the binding sites are not confined to 3 0 untranslated regions but also occur in the 5 0 untranslated regions. Moreover, miRNAs can also upregulate translation under certain circumstance and cell state. [3] [4] [5] It is believed that miRNAs have the potential to regulate about 30% of all human genes. Each miRNA can target up to 200 transcripts directly or indirectly, and multiple miRNAs can target a given gene. Due to the broad targeting ability, miRNAs have the potential to have central roles in physiological and pathological conditions, including cell differentiation, development, apoptosis and involving in the pathogenesis of several cancer types including colorectal cancer (CRC). [6] [7] [8] Recent studies have documented the association between the aberrant expression of miRNAs and the pathogenesis of CRC. Several miRNAs were differentially expressed between normal tissue and tumor subtypes, and microsatellite status for the majority of cancers could be correctly predicted based on miRNA expression profiles, indicating a potential role of miRNAs in diagnosis and treatment CBC. [9] [10] [11] However, in cancer cells, the expression of tumor-suppressor genes and oncogenes is drastically dysregulated by complex gene regulatory networks consisting of miRNAs, and the potential regulatory circuitry afforded by miRNAs is extremely complex. Therefore miRNA-target and functionally related gene sets or pathways would certainly help us further elucidate the pathogenesis of CRC.
A proliferation-inducing ligand (APRIL), also known as TALL-2 and TNFSF13, is a recently found new member of tumor necrosis factor's (TNF) superfamily.
12-14 APRIL expression is low in various normal cells, such as monocytes, dendritic cells and T cells, and so on. However, studies have confirmed that it is overexpressed in many tumor tissues and many tumor cell lines, especially in the digestive system carcinomas, such as colon carcinoma, pancreatic cancer, gastric cancer, hepatoma and esophageal carcinoma, which suggests that APRIL has an important role in the occurrence and development of these tumors. [15] [16] [17] [18] [19] Our previous experiments have further confirmed that APRIL is overexpressed in CRC tumors, yet, it is not expressed or has a weak expression in normal colon mucosa tissues. Moreover, several CRC cell lines have been screened and it has been found that SW480 cell line is highly expressed in the APRIL gene. 20 In the current investigation, we analyzed whether APRIL-knockdown had the inhibitory effect on the growth of SW480 cells, meanwhile, we explored the transcriptional changes that occur in APRIL-knockdown SW480 cells and investigate if these changes could be related to miRNAs. We determined functionally related gene sets or pathways to reveal the functional correlation between differentially expressed mRNAs and miRNAs, to investigate the possible mechanisms of miRNA-target regulating the function of APRIL gene in CRC cells and probe the feasibility of gene therapy for APRIL-positive CRC.
Materials and methods

Cell culture
Human CBC cell line SW480 (Academy of life science, Shanghai, China) were maintained in Dulbecco's modified Eagle's medium (Invitrogen, San Diego, CA) supplemented with 10% fetal bovine serum (Hyclone, Logan, UT) and antibiotics (100 mg ml À1 streptomycin and 100 U ml À1 penicillin) at 371C in humidified incubator containing 5% CO2.
Construction and transfection of recombinant vector
The self-complementary hairpin DNA oligos targeting APRIL mRNA were synthesized; the sequences were 5 0 -GATCCGCAACCTTCTTCCCTTCTGCTTCAAGAGA GCAGAAGGGAAGAAGGTTGTTTTTGGAAA-3 0 and 5 0 -AGCTTTTCCAAAAAACAACCTTCTTCCCTTCTG CTCTCTTGAAGCAGAAGGGAAGAAGGTTGCG-3 0 , named as siRNA-APRIL, including 9-nt loop sequences (underlined). A negative control to DNA oligos nontargeting APRIL mRNA was also designed; the sequences were 5 0 -GATCCGTTCTCCGAACGTGTCACGTTTCA AGAGAACGTGACACGTTCGGAGAATTTTTTGGA AA-3 0 and 5 0 -AGCTTTTCCAAAAAATTCT CCGAAC GTGTCACGTTCTCTTGAAACGTGACACGTTCGGA GAACG-3 0 , named as small interfering (si)RNA control. DNA oligos were annealed and inserted into pGCsi/H1/ Neo/GFP plasmid vector (Genechem, Shanghai, China). SW480 cells were seeded at a concentration of 2 Â 10 6 per six well. Next day, the recombinant vectors were transiently transfected SW480 cells with lipofectamine 2000 (Invitrogen). After 72 h of transfection, cells were harvested for the following analyses.
Analysis of APRIL mRNA by real-time PCR
The analysis was performed by LightCycler 1.5 Instrument (Roche Applied Science, Basel, Switzerland). A standard curve for APRIL was created using serially diluted total RNA and used to quantify relative APRIL mRNA levels. The sequences of the APRIL gene primers were as follows: forward primer, 5 0 -ACTCTCAGTTGCCCTCTGGTTG-3 0 and reverse primer, 5 0 -GGAACTCTGCTCCGGGAGAC TC-3 0 , the product was 187 bp. The 18S rRNA was served as a control for normalization, forward primer, 5 0 -GTT CTTAGTTGGTGGAGCGATTT-3 0 and reverse primer, 5 0 -GGCTGAACGCCACTTGTCC-3 0 , the product was 131 bp.
Western blot analysis
The SW480 cells were lysed with denaturing SDSpolyacrylamide gel electrophoresis sample buffer using standard methods. Protein lysates were separated by 10% SDS-polyacrylamide gel electrophoresis and transferred onto nitrocellulose membranes. The membranes were blocked with Tris-buffered saline containing 0.1% Triton X-100 and 5% non-fat milk overnight at 4 1C, then incubated with anti-human APRIL antibody and b-actin (Santa Cruz Biotechnology, Santa Cruz, CA) at 4 1C overnight. After washing, the membranes were incubated with HRP-conjugated mouse immunoglobulin at room temperature for 2 h. Signal detection was carried out with an ECL system (Amersham Pharmacia, Piscataway, NJ).
CCK-8 assay cell growth viability
Cells at a concentration of 5Â10 3 per well were seeded in the 96-well plate and incubated for 24 h. Seventy-two hours after transfection, cell growth viability was measured with a Cell Counting Kit-8 (Beyotime, Shanghai, China), following the manufacturer's instructions. Absorbance (A) was then recorded at 450 nm using Elx800 Reader (Bio-Tek Instruments, Winooski, VT).
Hoechst 33258 staining Cells were fixed with 4% formaldehyde in phosphatebuffered saline for 10 min, stained by Hoechst 33258 (Beyotime) for 10 min, and then subjected to fluorescence microscopy (Leica Microsystems, Wetzlar, Germany). After treatment with siRNA-APRIL, the change of nuclear chromatin condensation was observed. At least 200 cells were counted for each sample, and a percentage of apoptotic cells was calculated as the ratio of apoptotic cells to total cell count.
Flow cytometry analysis
The SW480 cells were harvested and fixed with ice-cold 70% ethanol, treated with RNase (0.25 mg ml À1 ) and resuspended in propidium iodide (50 g ml
À1
) at room temperature. Propidium iodide-stained cells were analyzed by flow cytometer (FACS Calibur, BD Biosciences, San Jose, CA).
Animal experiments
All animal experiments were performed in compliance with the institutional guidelines set by the Animal Care and Research Ethical Committee, College of Medicine, Nantong University. SW480 cells (1 Â 10 6 cells in 100 ml) were injected subcutaneously into the flanks of each 8-week-old BALB/c nude mouse and allowed to develop measurable tumors. Then, siRNA-APRIL or siRNA control 5 mg per mouse was directly injected into the tumors every 3 days, the mice treated with phosphatebuffered saline were used as controls. The tumor volumes were calculated by the following formula: V ¼ pab Genome-wide gene expression analysis Total RNAs were harvested using TRIzol (Invitrogen) and the RNeasy kit (Qiagen, Venlo, The Netherlands) according to manufacturer's instructions. After having passed RNA measurement on the ND-1000 (Nanodrop, Wilmington) and denaturing gel electrophoresis, the samples were labeled using a NimbleGen One-Color Labeling Kit and hybridized in NimbleGen Hybridization System (Roche, Madison, WI). After hybridization and washing, the processed slides were scanned with the GenePix 4000B microarray scanner (Axon Instruments, Union City, CA). Raw data were extracted as pair files by NimbleScan 2.5 software. The software's implementation of robust multichip average offers quantile normalization and background correction, as described by Irizarry et al. 21, 22 Differentially expressed genes were identified through fold-change screening between the two groups obtained from the experiments. The threshold we used to screen up or downregulated genes was fold changeX2.0.
miRNA microarray analysis and targets prediction Total RNAs were harvested using TRIzol (Invitrogen) and RNeasy mini kit (Qiagen) according to manufacturer's instructions. Then the samples were labeled using the miRCURY Hy3/Hy5 Power labeling kit and hybridized on the miRCURY LNA Array 11.0 (Exiqon, Vedbaek, Denmark). The samples were hybridized on a hybridization station. Scanning was performed with the GenePix 4000B microarray scanner (Axon). Microarray images were analyzed using the Genepix Pro 6.0 software. We used median normalization method to obtain normalized data ('normalized data' ¼ (foregroundÀbackground)/ median), the median was 50 percent quantile of miRNA intensity, which was larger than 50 in all samples after background correction. The threshold value we used to screen up and downregulated miRNAs was fold changeX2.0.
Genes previously reported as targets for the significantly regulated miRNAs, and differentially regulated in APRIL-knockdown cells, were obtained from miRwalk (http://www.ma.uni-heidelberg.de/apps/zmf/mirwalk). In addition, targets for the significantly regulated miRNAs, in the genes differentially regulated in APRIL-knockdown cells, were predicted using three algorithms: TargetScan (http://www.targetscan.org), miRanda (http:// www.microrna.org) and miRDB (http://mirdb.org/miRDB).
Pathway analysis
The pathways affected in APRIL-knockdown SW480 cells were determined for the significantly regulated genes from KEGG (http://www.genome.jp/kegg), GenMAPP (http://www.genmapp.org), Biocarta (http://www.biocarta. com) and PharmGKB (http://www.pharmgkb.org). To check whether significantly regulated genes are overrepresented in a pathway in APRIL-knockdown cells or not, an overrepresentation analysis (ORA) by Fisher's exact test without correction for multiple testing was used.
Pathways showing P-value o0.05 were considered as significantly enriched.
Quantitative analysis of miRNAs by real-time PCR PCR assays for miRNAs were performed using 'TaqMan MicroRNA Assays'. Real-time PCR was performed using a standard TaqMan PCR kit protocol on the Applied Biosystems 7000 Sequence Detection System (Applied Biosystems, Foster City, CA). U6 snRNA was used as a control and the comparative CT method for relative quantitation of gene expression was used to determine miRNA expression levels.
Results
APRIL-knockdown suppresses the growth of SW480 cells
To evaluate the expression level of APRIL mRNA and protein in siRNA-APRIL transfected cells, real-time reverse transcriptase PCR and western blot analysis were performed 72 h after transfection. Both APRIL mRNA and protein level in siRNA-APRIL transfected cells were drastically reduced, as compared with the non-transfected control and siRNA control transfected ones (Po0.05) (Figure 1a and b), whereas no difference was observed in non-transfected control and siRNA control transfected cells. To further evaluate whether silencing the APRIL gene may suppresses the growth of SW480 cells, CCK-8 assay cell growth viability, Hoechst 33258 staining and flow cytometry analysis were performed 72 h after transfection. As shown in Figure 1c , cell growth viability was significantly inhibited in siRNA-APRIL transfected cells, as compared with the non-transfected control and siRNA control transfected ones (Po0.05). Hoechst 33258 staining showed that condensed bright apoptotic nuclei were readily observed in siRNA-APRIL transfected cells (Figure 1d ). SiRNA-APRIL on the induction of apoptosis in SW480 cells was further confirmed by flow cytometry with PI staining. The percentage of sub-G1 cells were significantly higher in siRNA-APRIL transfected cells, as compared with the non-transfected control and siRNA control transfected ones (Po0.05). Moreover, cell cycle analysis showed that most siRNA-APRIL transfected cells were arrested in G0/G1 phase (Figure 1e ). However, there was no obvious difference between non-transfected control and siRNA control transfected cells. Our results showed that siRNA-APRIL, as a specific RNA interference target, can efficiently suppress the growth of SW480 cells.
SiRNA-APRIL inhibits tumor growth in vivo
To assess the effects of siRNA-APRIL on the in vivo growth of CRC cells, we used a xenograft model in which the SW480 cells were subcutaneously injected into the flanks of athymic mice and were allowed to develop measurable tumors. Then the mice were treated with siRNA-APRIL, siRNA control or phosphate-buffered saline (non-transfected control) every 3 days. There was no animal death in the course of the treatment and no other complications such as skin necrosis were detected due to infection. Intra-tumor injection with siRNA-APRIL could significantly suppress the growth of tumors, compared with being injected siRNA control and non-transfected control (Po0.05) (Figure 2a  and b) . Microscopically, in the non-transfected control and siRNA control groups, the structure of tumor cells was relatively complete, the cells were abundant and arranged densely. In siRNA-APRIL group, the tumor lesions were small. A lot of necrosis tumor cells and large cellular interval were observed (Figure 2c ).
Profiling miRNA expression changes in APRIL-knockdown SW480 cells To investigate the changes in miRNA profiles, we examined the expression of miRNAs between siRNA-APRIL transfected cells and siRNA control transfected cells using locked nucleic acid-based miRNA-chips. We identified 41 differentially regulated miRNAs according to the threshold value of up and downregulated miRNAs. Out of 41 miRNAs, 12 were upregulated and 29 were downregulated in APRIL-knockdown SW480 cells (Figure 3a) .
We verified the changes in the expression patterns of some of these miRNAs using quantitative real-time PCR. We verified the expression changes of the two upregulated miRNAs, miR-145 and miR-24, and three down-regulated miRNAs, miR-185, miR-144 and miR-9. In line with the expression on the miRNA-arrays, in quantitative PCR analysis, miR-145 and miR-24 were about 4.5 and 2.7 fold upregulated in siRNA-APRIL-transfected cells, 
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respectively, as compared with siRNA control transfected ones. On the other hand, miR-185, miR-144 and miR-9 were about 2.3, 3.5 and 3.1 fold downregulated in siRNA-APRIL-transfected cells, respectively, as compared with siRNA control transfected ones, which also exhibited a relatively good correlation to the microarray data (Figure 3b ).
Microarray analysis of genes involved in APRILknockdown SW480 cells
To study the changes of genome-wide gene expression regulation in APRIL-knockdown SW480 cells, we performed gene expression profiling analysis on siRNA-APRIL-transfected cells and siRNA control transfected cells. In total, 1105 genes were found to be significantly regulated, the transcripts of 407 genes were downregulated, whereas the transcripts of 698 genes were upregulated in APRIL-knockdown SW480 cells (Supplementary data 1). Table 1 shows the top 20 significantly up/downregulated genes. Several genes such as TNFSF13 (APRIL), CDK2, CDK4, and so on, were strongly differentially regulated in expected orientations, showing the reliability of mRNA expression profiles.
To reveal the functional meaning of differentially regulated genes in APRIL-knockdown SW480 cells, we analyzed the biological pathways these genes may be involved in. We identified 168 (15. 
Identifying miRNA-target interaction
We then mapped the possible targets of the differentially regulated miRNAs (41 obtained from miRNA profiling experiment) to differentially regulated genes (1105 obtained from mRNA expression experiment). We first looked for already reported targets by comparing the list of differentially regulated miRNAs and the genes to the available miRNA-target interactions present in the miRwalk database. A total of 41 genes are reported as targets of 10 miRNAs. Out of these 41 genes, nine genes are known to affect 38 pathways. Ten pathways were significantly enriched in APRIL-knockdown SW480 cells, as revealed by ORA (Supplementary data 3) . Secondly, we mapped the differentially regulated genes for miRNA targets for the differentially regulated miRNAs using three tools, TargetScan, miRanda and miRDB. Only commonly predicted targets for different miRNAs were taken for further analysis. A number of 128 genes were predicted as targets of 17 miRNAs, out of which 10 genes participate in regulating 27 pathways. Eleven pathways were significantly enriched in APRIL-knockdown SW480 cells, as revealed by ORA (Supplementary data 3) . Altogether, we obtained 152 differentially expressed genes A total of 1105 genes were differentially regulated on NimbleGen chips whereas 41 miRNAs were differentially changed on Exiqon chips. Target genes for differentially expressed miRNAs were obtained from miRwalk as well as TargetScan, miRanda and miRDB and 152 resulting genes were overlapped with differentially expressed mRNAs. Functionally related gene sets or pathways, determined for differentially expressed mRNAs and predicted target genes of differentially expressed miRNAs, were compared and the overlap gave 48 associated gene sets, out of which 13 were significantly enriched pathways.
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Discussion CRC is one of the most prevalent and deadly cancers in the Western world. Despite advances in surgery, radiotherapy and chemotherapy, the long-term survival rates of the CRC have not significantly improved. Therefore, novel treatment need to be developed to add to the therapeutic armamentarium. [23] [24] [25] RNA interference is a sequence-specific post-transcriptional gene silencing mechanism, which has become a powerful tool for investigating gene function by reverse genetics. This new approach has been widely used in the study of gene therapy for cancer by vector-based strategies for delivery of siRNA into mammalian cells. 26, 27 In the current investigation, we used a combinatorial approach involving microarray analysis and data mining to explore the possible pathways involvement in APRIL-silencing SW480 cells. With the deeper understanding of the molecular mechanism, RNA interference technology for CBC therapeutics may become an attractive and promising modality for gene therapy.
Our study profiles the changes of the mRNA transcripts in APRIL-knockdown cells. In total, 1105 genes were found to be significantly regulated (407 down; 698 up) (Supplementary data 1). Then we identified 168 out of 1105 significantly regulated genes involved in 242 pathways from four databases, GenMAPP, KEGG, PharmGKB and Biocarta. ORA showed that 21 pathways were significantly enriched in APRIL-knockdown SW480 cells (Table 2 , Figure 4 , Supplementary data 2). Some signal pathways such as apoptosis, cell cycle, inhibition of matrix metalloproteinases, and so on, were significantly regulated in APRIL-knockdown SW480 cells, which can further elucidate the potential mechanisms about siRNA-APRIL efficiently suppressing the growth of CRC cells in vitro and in vivo.
On the other hand, miRNAs have emerged recently as key regulators of gene expression in CBC. [8] [9] [10] Our miRNA study shows that changes in gene expression also involve miRNAs in APRIL-knockdown SW480 cells. A total of 41 differentially regulated miRNAs were identified (29 down; 12 up) (Figure 3a) . MiR-145, one of up-regulated miRNAs in our study, has frequently been reported as downregulated in colon cancers and some kinds of CRC cell lines. Furthermore, miR-145 has been demonstrated to have tumor-suppressor function when overexpressed in cancer cells. 9, [28] [29] [30] [31] In agreement with previous reports, our results indicate that the upregulated miR-145 may have an important role in the growth of APRIL-knockdown SW480 cells.
Then we compared the mRNA and miRNA profiles, differentially regulated in APRIL-knockdown SW480 cells. Target genes for differentially expressed miRNAs were obtained from miRwalk as well as TargetScan, miRanda and miRDB and 152 resulting genes were overlapped with differentially expressed mRNAs. There were some genes, which had been reported as miRNA target, like insulin receptor substrate 1 (IRS1) as a target of miR-145, cyclin-dependent kinase 4 (CDK4), prostaglandin-endoperoxide synthase 1 (PTGS1) and tumor necrosis factor receptor superfamily member 10B (TNFRSF10B) as targets of miR-144, cyclin-dependent kinase 6 (CDK6) as a target of miR-15a as well as miR-9, and so on. Functionally related gene sets or pathways, determined for differentially expressed mRNAs and predicted target genes of differentially expressed miRNAs, were compared and the overlap gave 48 associated gene sets, out of which 13 were significantly enriched pathways (Figure 4 , Supplementary data 3).
Parallel profiling of the transcripts as well as miRNAs on the same set of samples gives us insight into potential interactions between miRNAs and differentially expressed targets in APRIL-knockdown SW480 cells. Some groups have reported miRNA can upregulate its target mRNA under certain circumstance and cell state, [3] [4] [5] however, a negative relationship of the expression pattern between miRNA and its target mRNA is an important parameter for determining their interactions because miRNA, in general, are regarded as negative regulators of their targets. We found 84 differentially expressed targets for 16 miRNAs, which had expression patterns in opposite direction. In total of 84 genes, 10 genes participate in regulating 30 pathways, and ORA showed 12 pathways that were significantly enriched.
The differentially regulated genes, such as CDK2, CDK4, CDK6 and cyclin-dependent kinase inhibitor 1A (CDKN1A), and so on, involve in significantly enriched pathways cell cycle: G1/S check point, cyclins and cell cycle regulation, influence of Ras and Rho proteins on G1 to S transition and p53 signaling pathway. The eukaryotic cell cycle is controlled by interconnected biochemical events that coordinate the transition of cells from one phase to another. CDKs, cyclins and CDK inhibitors (CKIs) are well recognized as essential regulators of cell cycle, their functions, activities and interactions as related to regulation of both progression of the cell cycle and maintenance of a balance between proliferation, quiescence and/or differentiation. 32, 33 Deregulation of the cell cycle contributes to the unrestrained proliferation in human cancer cells. 34 Our cell cycle analysis showed that siRNA-APRIL promoted G0/G1 phase arrest and enhanced the percentage of sub-G1 cells in APRIL-knockdown SW480 cells, indicating that siRNA-APRIL, as a potential anticancer agents, may regulate the cell cycle through above-mentioned signal transduction pathways and result in cytostatic and even apoptotic effects.
In addition, our results also suggest that siRNA-APRIL suppresses the growth of SW480 cells that may involve in other anticancer mechanisms, such as inhibiting a cell's invasion, metastasis, growth and migration through inhibition of matrix metalloproteinases pathway and facilitating cell apoptosis through induction of apoptosis through DR3 and DR4/5 death receptors pathway, and so on. Our current study highlights the possible mechanisms of miRNA-target regulating the function in APRIL-knockdown SW480 cells. Thus, siRNA-APRIL holds great promise as a novel gene therapy approach for APRIL-positive CRC treatment.
Furthermore, overexpressing miRNAs result in repressed targets, both at protein and messenger levels. Few studies have appeared showing the use of proteomics based approaches for identifying specific miRNA targets. 35, 36 Our study has showed that mRNA profiling is a valuable tool for studying mRNA-miRNA interaction, however, to offer more evidence for gene therapy based on RNA interference technology, additional information on fine-tuning of proteome expression should be obtained by including proteomics approaches.
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